Abstract
Lack of high-molecular-weight (HMW) von Willebrand factor (vWF) multimers is one of the most critical causes of bleeding complication in long-term management of continuous-flow (CF) left ventricular assist device (LVAD) patients. EVAHEART (SunMedical Technology Research Co., Japan) LVAD is an implantable centrifugal blood pump which has characterized by relatively low share stress pump. Aim of this study was to investigate the vWF activities in our new pump.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.